One of the most intriguing areas of microbiome investigation concerns how our gut microbes affect our central nervous system (CNS). A variety of studies have shown that specific behavioral traits (inquisitiveness, sociability, anxiety, depression) differ when comparing GF mice and conventional mice. Amazingly, when GF mice are colonized by bacteria, these traits normalize. In addition, some behavioral traits are reproducibly transferred between mice via FMT. The influence of the microbiome is heritable as well, because the gut microbiome of pregnant mice influences the neurodevelopment of their offspring. Intriguingly, bacteria that stimulate maternal secretion of the pro-inflammatory cytokine IL-17 give rise to pups (baby mice) that display repetitive and antisocial behaviors.
How do we account for such curious observations? There are at least three ways the microbiome can influence the CNS (figure 24.6). First as we have seen, the microbiome has a profound impact on the immune system, which in turn modulates the CNS. One documented way in which this occurs is through microbial regulation of the balance between pro- and anti-inflammatory cytokines (figure 24.4). When pro- inflammatory cytokines reach the brain, they alter the function of neurons and CNS macrophages, called microglia. For example when lipopolysaccharide (LPS) crosses the gut, it triggers the production of pro-inflammatory cytokines, which in turn are responsible for the behaviors we associate with being sick: loss of appetite, decreased motor activity, loss of sociability, and reduced cognition.
-Another mechanism that helps mediate the gut-brain axis is a direct pathway from gut to brain. This is possible because the GI tract is lined with a network of nerves, called the enteric nervous system, that is connected to the CNS via the vagus nerve. Gut bacteria directly stimulate neurons within the enteric nervous system, which then communicate with the vagus nerve. The vagus nerve in turn transmits signals to the brain. The vagus nerve can differentiate between stimuli from normal microbiota and pathogens even in the absence of inflammation, although how this fascinating feat is possible remains under investigation.
Finally, as suggested by experiments in which butyrate and FMT had similar effects on the behavior of GF mice, soluble microbial products can impact the CNS. To understand this, we must first consider the CNS as a site that is set apart from the remainder of the body by the blood-brain barrier (BBB). The BBB is lined with cells that protect the CNS from normal blood components as well as toxins and infectious agents. This is largely due to impermeable connections, called tight junctions, between the cells that make up the BBB. Once again, a flurry of research was triggered by an observation made in GF mice: Their BBBs have the undesirable quality of being more permeable than conventional mice. And once again, it is SCFAs, particularly butyrate, that help maintain the BBB as an impenetrable barricade. Because SCFAs are most abundant when mice or humans eat a high-fiber diet, the broader implication is that one's diet can govern the entry of metabolites and other blood-borne compounds to the CNS.
The unexpected influence gut microbiota has on behavior, documented in animals and some human trials, has unleashed a torrent of studies into how the microbiome may mediate neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Autism spectrum disorder (ASD) has also garnered a great deal of attention. This reflects evidence that the establishment of a functional microbiome has long-lasting and important effects on behavior and perhaps on neural development within the first 3 years of life, when most children are diagnosed with ASD. How our microbiomes impact both neurodevelopment and degeneration are intriguing areas of investigation that will no doubt continue to reveal unexpected findings.